Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-27

Clinical Trial Update: Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial is evaluating superselective intra-arterial cerebral infusion of temsirolimus for high-grade glioma, including glioblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temsirolimus (temsirolimus)

Snippet

Sponsor: Nader Sanai | Conditions: High Grade Glioma, Glioma | EARLY_Phase 1 | Status: RECRUITING